Yahoo India Web Search

Search results

    • Med in India: Quality, affordability, access

      Med in India: Quality, affordability, access

      The Economic Times· 18 hours ago

      In her budget speech, Nirmala Sitharaman announced the exemption of trastuzumab deruxtecan, osimertinib and durvalumab, three targeted immunotherapy...